Skip to main content

Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil.

Publication ,  Journal Article
Moon, RE; Martina, SD; Peacher, DF; Potter, JF; Wester, TE; Cherry, AD; Natoli, MJ; Otteni, CE; Kernagis, DN; White, WD; Freiberger, JJ
Published in: Circulation
March 8, 2016

BACKGROUND: Swimming-induced pulmonary edema (SIPE) occurs during swimming or scuba diving, often in young individuals with no predisposing conditions, and its pathophysiology is poorly understood. This study tested the hypothesis that pulmonary artery and pulmonary artery wedge pressures are higher in SIPE-susceptible individuals during submerged exercise than in the general population and are reduced by sildenafil. METHODS AND RESULTS: Ten study subjects with a history of SIPE (mean age, 41.6 years) and 20 control subjects (mean age, 36.2 years) were instrumented with radial artery and pulmonary artery catheters and performed moderate cycle ergometer exercise for 6 to 7 minutes while submersed in 20°C water. SIPE-susceptible subjects repeated the exercise 150 minutes after oral administration of 50 mg sildenafil. Work rate and mean arterial pressure during exercise were similar in controls and SIPE-susceptible subjects. Average o2 and cardiac output in controls and SIPE-susceptible subjects were: o2 2.42 L·min(-1) versus 1.95 L·min(-1), P=0.2; and cardiac output 17.9 L·min(-1) versus 13.8 L·min(-1), P=0.01. Accounting for differences in cardiac output between groups, mean pulmonary artery pressure at cardiac output=13.8 L·min(-1) was 22.5 mm Hg in controls versus 34.0 mm Hg in SIPE-susceptible subjects (P=0.004), and the corresponding pulmonary artery wedge pressure was 11.0 mm Hg versus 18.8 mm Hg (P=0.028). After sildenafil, there were no statistically significant differences in mean pulmonary artery pressure or pulmonary artery wedge pressure between SIPE-susceptible subjects and controls. CONCLUSIONS: These observations confirm that SIPE is a form of hemodynamic pulmonary edema. The reduction in pulmonary vascular pressures after sildenafil with no adverse effect on exercise hemodynamics suggests that it may be useful in SIPE prevention. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00815646.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 8, 2016

Volume

133

Issue

10

Start / End Page

988 / 996

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Swimming
  • Sildenafil Citrate
  • Risk Reduction Behavior
  • Pulmonary Wedge Pressure
  • Pulmonary Edema
  • Oxygen Consumption
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moon, R. E., Martina, S. D., Peacher, D. F., Potter, J. F., Wester, T. E., Cherry, A. D., … Freiberger, J. J. (2016). Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil. Circulation, 133(10), 988–996. https://doi.org/10.1161/CIRCULATIONAHA.115.019464
Moon, Richard E., Stefanie D. Martina, Dionne F. Peacher, Jennifer F. Potter, Tracy E. Wester, Anne D. Cherry, Michael J. Natoli, et al. “Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil.Circulation 133, no. 10 (March 8, 2016): 988–96. https://doi.org/10.1161/CIRCULATIONAHA.115.019464.
Moon RE, Martina SD, Peacher DF, Potter JF, Wester TE, Cherry AD, et al. Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil. Circulation. 2016 Mar 8;133(10):988–96.
Moon, Richard E., et al. “Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil.Circulation, vol. 133, no. 10, Mar. 2016, pp. 988–96. Pubmed, doi:10.1161/CIRCULATIONAHA.115.019464.
Moon RE, Martina SD, Peacher DF, Potter JF, Wester TE, Cherry AD, Natoli MJ, Otteni CE, Kernagis DN, White WD, Freiberger JJ. Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil. Circulation. 2016 Mar 8;133(10):988–996.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 8, 2016

Volume

133

Issue

10

Start / End Page

988 / 996

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Swimming
  • Sildenafil Citrate
  • Risk Reduction Behavior
  • Pulmonary Wedge Pressure
  • Pulmonary Edema
  • Oxygen Consumption
  • Middle Aged
  • Male
  • Humans